Serum and Urinary NGAL and Cystatin C Levels as Diagnostic Tools for Acute Kidney Injury and Chronic Kidney Disease: A Histobiochemical Comparative Study
Authors:
- 5 August 2019
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 25 (10) , 1122-1133
Abstract
Background: High global incidence of acute kidney injury (AKI) is an observable complication in critically ill patients. Long-term disease and medication complexity contribute to devastating chronic kidney disease (CKD), diminishing quality of life.Objective: To establish new biomarkers to guide patient care and facilitate novel therapeutics development.Methods: Serum and urinary levels of creatinine, CysC, and NGAL were estimated in 86 renal patients and compared with healthy controls for AKI and CKD categorization. Creatinine and CysC measurements were used to estimate GFR. Kidney biopsies were prepared for light microscopy for further characterization. Patients’ demographic data were used in group association studies.Results: Thirty-six patients met the criteria for AKI and 50 for CKD. Both mean serum and urine creatinine levels were significantly elevated by 2.8 and 2.6, respectively, from baseline in 48 h in the AKI group but not CKD group. Mean serum Cystatin C (CysC) values were higher than controls but similar in both disease states, while urine levels were slightly higher in CKD patients, and remained steady by the end of the follow-up (EF-Up). Further, a significant 2.9-fold and 5.5-fold (p=0.001) increase in serum NGAL in AKI and CKD, respectively, and a dramatic 7.1-factor reduction in AKI group, but no appreciable change in the CKD group from admission to EF-Up were observed. Similarly, urine NGAL level for AKI and CKD increased 3.2-fold and 6-fold respectively, on admission, which decreased moderately with the AKI group (2.5-fold) but increased by a factor of 1-8 (10.7- fold; p=0.001) at EF-Up. ROC assessment curve revealed relatively higher NGAL performance at good predictive values than CysC (p < 0.009).Conclusion: Our data demonstrated creatinine elevation by a factor > 2 in 48 h in AKI group but not CKD group, which returned close to normal levels by the EF-Up, an indication of abrupt renal injury in AKI, compared with a persistent effect in the CKD group. Both serum and urine NGAL sensitivity and specificity provided powerful discriminative tool between AKI and CKD by reduction in the AKI group and an increase in the CKD group by the EF-UP, thus, contributing in establishing the basis for AKI and CKD classification. CysC, however, displayed less sensitivity than NGAL, indicating effects by enigmatic non-specific factors.Keywords
Funding Information
- Institute of Scientific Research and Islamic Heritage Revival (Institute of Manuscripts and Islamic Heritage) at Umm Al-Qura University (43409054)
This publication has 43 references indexed in Scilit:
- Chronic kidney disease: global dimension and perspectivesThe Lancet, 2013
- Occupational risk and chronic kidney disease: a population-based study in the United States adult populationInternational Journal of Nephrology and Renovascular Disease, 2013
- Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin CNew England Journal of Medicine, 2012
- Socioeconomic Status and Chronic Kidney Disease at Presentation to a Renal Service in the United KingdomClinical Journal of the American Society of Nephrology, 2008
- Gender differences in predictors of the decline of renal function in the general populationKidney International, 2008
- Gender differences in chronic kidney diseaseKidney International, 2008
- Overweight, Obesity, and the Development of Stage 3 CKD: The Framingham Heart StudyAmerican Journal of Kidney Diseases, 2008
- Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damageKidney International, 2007
- Amelioration of Ischemic Acute Renal Injury by Neutrophil Gelatinase-Associated LipocalinJournal of the American Society of Nephrology, 2004
- Risk of developing end-stage renal disease in a cohort of mass screeningKidney International, 1996